Age as a predictive factor of disease activity after discontinuation of Disease Modifying Treatment in Multiple Sclerosis

被引：0
|
作者：
Soares, Mafalda Delgado [1 ,2 ]
Faustino, Patricia [1 ,2 ]
Sequeira, Joao [2 ]
Marques, Jose Pinto [2 ]
Sousa, Ana [2 ]
Grine, Teresa [2 ]
Mateus, Claudia [2 ]
Encarnacao, Susana [2 ]
Santos, Ana Catarina [2 ]
Gama, Anabela [2 ]
Capela, Carlos [2 ]
Ladeira, Filipa [2 ]
机构：
[1] Ctr Hosp Univ Lisboa Cent, Neurol, Dept Lisbon, Lisbon, Portugal
[2] Ctr Hosp Univ Lisboa Cent, Multiple Sclerosis Ctr Integrated Responsabil, Lisbon, Portugal
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1521/1363
引用
收藏
页码：970 / 971
页数：2
相关论文
共 50 条
  • [41] Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients
    Bianco, Assunta
    Lucchini, Matteo
    Totaro, Rocco
    Fantozzi, Roberta
    De Luca, Giovanna
    Di Lemme, Sonia
    Presicce, Giorgia
    Evangelista, Luana
    Di Tommaso, Valeria
    Pastorino, Roberta
    De Fino, Chiara
    De Arcangelis, Valeria
    Centonze, Diego
    Mirabella, Massimiliano
    NEUROTHERAPEUTICS, 2021, 18 (04) : 2598 - 2607
  • [42] Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients
    Ghezzi, A.
    Rocca, M. A.
    Baroncini, D.
    Annovazzi, P.
    Zaffaroni, M.
    Minonzio, G.
    Comi, G.
    Filippi, M.
    JOURNAL OF NEUROLOGY, 2013, 260 (01) : 327 - 329
  • [43] Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients
    A. Ghezzi
    M. A. Rocca
    D. Baroncini
    P. Annovazzi
    M. Zaffaroni
    G. Minonzio
    G. Comi
    M. Filippi
    Journal of Neurology, 2013, 260 : 327 - 329
  • [44] Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients
    Baroncini, D.
    Ghezzi, A.
    Rocca, M. A.
    Annovazzi, P. O.
    Bianchi, A.
    Minonzio, G.
    Zaffaroni, M.
    Filippi, M.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 219 - 220
  • [45] Discontinuation of disease-modifying therapies in relapsing remitting multiple sclerosis - outcome and prognostic factors
    Bsteh, G.
    Feige, J.
    Ehling, R.
    Hegen, H.
    Auer, M.
    Di Pauli, F.
    Deisenhammer, F.
    Berger, T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 644 - 644
  • [46] DISCOntinuation of disease-modifying therapies in Multiple Sclerosis (DISCOMS): Primary results of the extension trial
    Corboy, John
    Engebretson, Eric
    Cutter, Gary
    Fox, Robert J.
    Kister, Ilya
    Miller, Aaron
    Morgan, Charity
    Seale, Rebecca
    Gustafson, Tarah
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 356 - 357
  • [47] Disease modifying therapies discontinuation in relapsing-remitting Multiple Sclerosis: a monocentric cohort study
    Pasca, M.
    Forci, B.
    Mechi, C.
    Mariottini, A.
    Barilaro, A.
    Massacesi, L.
    Repice, A. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 464 - 465
  • [48] Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study
    Villaverde-Gonzalez, Ramon
    Candeliere-Merlicco, Antonio
    Aranzazu Alonso-Frias, Maria
    Aparicio Castro, Eladio
    Carrillo Alcaraz, Andres
    Mallada Frechin, Javier
    Perez Sempere, Angel
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 46
  • [49] Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis
    Coerver, E. M. E.
    Bourass, A.
    Wessels, M. H. J.
    van Kempen, Z. L. E.
    Jasperse, M. M. S.
    Tonino, B. A. R.
    Barkhof, F.
    Mostert, J.
    Uitdehaag, B. M. J.
    Killestein, J.
    Strijbis, E. M. M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 74
  • [50] Disease-specific quality of life in multiple sclerosis: the effect of disease modifying treatment
    Lily, O.
    McFadden, E.
    Hensor, E.
    Johnson, M.
    Ford, H.
    MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (06) : 808 - 813
12345